We performed an audit of the insertion of the Single Use Portex Laryngeal Mask in 400 patients. Insertion was successful at first attempt in 335 out of 400 patients (83.8%). However in 15 patients (3.8%), the Portex laryngeal mask could not be placed despite repeated attempts. In 12 of these 15 patients (80%), a standard Laryngeal Mask Airway (LMA) was successfully placed. After the completion of the audit, 22 out of 29 anaesthetists (75.9%), who had inserted 5 Portex laryngeal masks, considered it inferior to the standard LMA. It would appear to us that the Portex laryngeal mask might need some design modifications to be a real alternative to the standard LMA.
The standard or classical laryngeal mask airway (LMA) is made of medical-grade silicone rubber (The Laryngeal Mask Company, Henley-on-Thames, U.K.), is reusable, and is sterilized by steam autoclaving 1 . Prions are novel proteinaceous-infectious agents that have been implicated in human transmissible spongiform encephalopathies such as variant Creutzfeldt-Jakob disease 2 . Many methods of decontamination and sterilization are claimed to be ineffective against prion proteins 2 . A recent study that examined 20 reused standard LMAs found that all of them tested positive for the presence of protein 3 . This raises the possibility that prions may be transmitted by reusable LMAs.
A new disposable, single-use laryngeal mask (Portex Soft Seal Laryngeal Mask, Kent, U.K.) was introduced into Australia in 2002. As there are no published reports of its performance, we planned an audit in a variety of clinical settings, and by a large number of anaesthetists of varying experience, to determine if the Portex laryngeal mask is a suitable replacement for the standard LMA.
DESIGN OF AUDIT
Consent for the audit was obtained from the Southern Tasmanian Health and Medical Human Research Ethics Committee and was to consist of the first 400 cases of its use at one hospital (Royal Hobart Hospital, Tasmania). No specific instructions or inservicing of the Portex laryngeal mask were given to members of the Anaesthetic Department, who were encouraged to use the Portex laryngeal mask whenever they would normally use the standard LMA. No restrictions were placed on any anaesthetic technique or drugs. No specific instructions were provided what to do when difficulty with placement was experienced.
Following insertion of the Portex laryngeal mask, the anaesthetist completed a one-page information sheet in theatre. Information gathered included demographic data, type of surgery, anaesthetic drugs used, size of the Portex laryngeal mask, and whether the cuff was adjusted prior to removal from the packet. Placement was assessed as first pass (insertion with one movement), first pass with adjustment (there was adjustment of the laryngeal mask following placement, but it was not removed from the mouth). If it had to be removed, the number of passes was recorded. Once the laryngeal mask was placed, the volume of air used to inflate the cuff was recorded. The seal was tested at 20 cmH 2 O and the anaesthetist recorded whether the laryngeal mask needed to be repositioned to get a good seal.
In the Recovery Room it was noted if blood was present on the Portex laryngeal mask after its removal and patients were asked to give a verbal analogue score (VAS; 0=no pain; 10=worst pain) for sore throat.
Following the completion of the audit, anaesthetists who had placed at least five of the Portex laryngeal masks were asked about their impressions of the new device and how they felt it compared to the standard LMA.
RESULTS
The Portex laryngeal mask is made of clear PVC and thus looks quite different from the standard LMA, which is made of silicone rubber. The stem of the Portex laryngeal mask has an outer diameter of 20 mm compared to the standard LMA, which has a diameter of 15 mm (own measurements). The Portex laryngeal mask lacks epiglottic bars.
Of the 400 patients studied, 241 (60.2%) were performed as day cases. The remainder were inpatients. There were 197 females and 203 males. Their mean age was 45.0 y (SD 19.4); weight 75.3 kg (17.9), and BMI 26.7 (6.1). The type of surgery, with patient numbers in brackets, was as follows: general surgery (96), gynaecology (84), orthopaedics (102), plastic surgery (58), urology (48) miscellaneous other (12). The following anaesthetic drugs were used (with patient numbers in brackets), prior to insertion of the Portex laryngeal mask: propofol (393), sevoflurane (7) , fentanyl (335), pethidine (1), morphine (21), remifentanil (5), muscle relaxants (6), diazepam (2), midazolam (311), droperidol (4) and metoclopramide (7) . Some patients received more than one drug.
A size #3 Portex laryngeal mask was used in 96 cases (24.0%), size #4 in 188 cases (47.0%), and size #5 in 116 cases (29.0%). The laryngeal mask was used as it came from the packet in 292 cases (73.0%), fully deflated in 78 (19.5%), partially deflated in 17 (4.25%) and extra air was placed prior to insertion in 13 cases (3.25%).
In 279 cases (69.75%), placement was successful at first pass, in 56 cases (14.0%) further manipulation was required without removal of the laryngeal mask from the mouth, and in 50 (12.5%) cases, two or more insertions were required. Despite numerous attempts in 15 cases (3.75%), the anaesthetist was unable to successfully place the Portex laryngeal mask. Failure to place the laryngeal mask was attributed to poor positioning on nine occasions, difficulty in placing the laryngeal mask on five occasions, and the tongue catching repeatedly on the laryngeal mask opening on one occasion. On seven occasions, difficulty was experienced with a size #5 Portex laryngeal mask and the anaesthetist resorted to a standard LMA #5 on one occasion, a standard LMA #4 four times and a standard LMA of unknown size twice. The remaining 8 failed attempts were with a size #4 Portex laryngeal mask and the airway was maintained with a standard LMA #4 once, a standard LMA of unknown size four times, and a face mask three times. Overall in 12 of the 15 cases (80%) where the anaesthetist was unable to place a Portex laryngeal mask, success was achieved with a standard LMA.
Following successful placement (n=385), the mean volume of air injected into the cuff to obtain an adequate seal on applying positive pressure of 20 cmH 2 O to the circuit was 10.5 ml (SD 10.2 ml). In 129 cases (33.5%), an adequate seal was obtained without any air being injected into the cuff. Overall, on 22 occasions (5.7%), the Portex laryngeal mask needed to be repositioned to obtain an adequate seal.
The mean duration of surgery was 49.8 min (28.8). Following removal of the Portex laryngeal mask, blood was seen on the laryngeal mask in 47 cases (12.2%), absent in 335 cases (87.0%) and not recorded on three occasions. The VAS for sore throat could not be assessed in 10 cases. In 255 cases (68.0%) the VAS for sore throat was 0, while only 16 patients (4.3%) reported a VAS for sore throat of 4 or greater. There appeared to be no association between severity of sore throat and duration of surgery or volume of air injected into the Portex laryngeal mask cuff.
After the completion of the audit, all 29 anaesthetists (19 consultants, 5 trainees with more than two years experience and 5 trainees with less than two years experience) who had inserted 5 or more Portex laryngeal masks were asked their opinion as to how the Portex laryngeal mask compared to the standard LMA. Twenty-two anaesthetists considered it inferior (76%), 6 (21%) felt it was equivalent, and only 1 (3%) rated it superior. Overall there appeared to be no difference between these assessments according to anaesthetic experience. Some of the advantages reported by the anaesthetists in this audit of the Portex laryngeal mask included the quality of the seal, that it was disposable, and the absence of epiglottic bars. Disadvantages included that it was too big and bulky, too stiff, that it didn't sit as well as the standard LMA, that it tended to rotate spontaneously, and that the tongue got caught up in the bowl. Several anaesthetists commented that once they started using a smaller size than they would with the standard LMA, the Portex laryngeal mask was much easier to use.
Of interest was a patient in the study who had had a similar procedure with a standard LMA a few 694 months earlier, and reported to the nurse in the recovery room on awakening, "I had a bigger lump in my mouth than last time."
DISCUSSION
Although transmission of prions or Creutzfeld-Jakob disease by saliva or blood has not been reported and the risk is considered to be negligible 2 , the difficulty of removing all protein from reusable LMAs has led to an interest in the use of disposable airway devices. We chose to audit the performance of the Portex Soft Seal Laryngeal Mask, a new single-use laryngeal mask to determine how well it performed as an airway device and to determine whether its performance was equal to the standard LMA.
Success of placement of the Portex laryngeal mask at first attempt in our study was only 84% if we adopt the same criteria as some of the other studies 4-8 (i.e., successful placement without removal from the mouth). This compares poorly when compared to the high success rate seen with the standard LMA in many studies.
However of greater concern was the failure rate of 3.8% with the Portex laryngeal mask in our study. This failure rate is considerably higher than studies that have examined the standard LMA, LMA-Unique, or Proseal LMA [4] [5] [6] [7] [8] . Also in our study, of the 80% of failures with the Portex laryngeal mask, a standard LMA was successfully placed.
The LMA-Unique is a disposable device and was introduced in September 1997 4 . This device is also manufactured with clear PVC and has dimensions identical to the standard LMA, but is stiffer and has a thicker cuff. A randomized study of 100 patients compared the standard LMA with the LMA-Unique and reported no failures in insertion of either device 4 . In one patient, the size #5 LMA-Unique had to be replaced with a tracheal tube for a persistent leak following positive pressure ventilation during the procedure. Although all patients were paralysed for this study, in contrast to only 6 out of 400 in our study, in the presence of adequate anaesthetic depth, muscle relaxation does not improve ease of insertion of the standard LMA 8 . There was also no association between incidence of sore throat and fibreoptic view of the larynx between the two LMAs. The impression of the authors was that although the LMA-Unique was similar in shape to the standard LMA, it was considerably stiffer which was an observation frequently made in our study of the Portex laryngeal mask.
A randomized, crossover study of 60 paralyzed, anaesthetized patients compared the standard LMA with the LMA-Unique and found that ease of inser-tion was similar and there were no failures 5 . There was no difference in first attempt success rates (97% vs 98%) and insertion times (15 s vs 13 s) for the LMA-Unique and standard LMA respectively. There were no differences in airway sealing pressure or fibreoptic position.
A two-year prospective survey of the classical LMA in 11910 patients inserted by both consultant and junior anaesthetists, reported success in 11887 patients (99.81%), and a tracheal tube was required in only 23 patients (0.19%) 6 . The reason for failure of the LMA was inadequate seal in 14 patients and failed placement in 9 patients. In a study comparing the standard LMA to the Proseal LMA, there were no failures in 192 insertions of the standard LMA, and only two failures out of 192 patients in the Proseal group (1.0%) 7 . In this study, the standard LMA was successfully placed at first attempt in 91% of cases and 83% of Proseal patients (a failed attempt was removal of the LMA from the mouth). There was only one failure of insertion in a study of 200 patients (0.5%) that compared insertion of the standard LMA either fully deflated or partially inflated 9 .
Following laryngeal mask insertion the incidence of sore throat varies from 5.8% to 34% 10 . The wide variation in these figures is presumably due to different skills and techniques among anaesthetists and to differences between individual anaesthetists and patients in the definition of sore throat. In a study examining insertion methods of the standard LMA (deflated cuff versus inflated cuff), patients were directly asked whether they had a sore throat on discharge from the recovery room 9 . There was a significantly higher incidence of sore throat in the group whose standard LMA was deflated (21.4%) on insertion compared to the group with inflated cuffs (4.1%). Overall 44 out of 190 patients (23%) complained of a sore throat following anaesthesia with a standard LMA 7 . This was moderate to severe in 4/190 patients (2.1%). This data is similar to our incidence of 4.2% of patients having a VAS of 4 or greater, or 32% having any sore throat at all.
Visible blood contamination has been reported as 12% following an examination of 50 LMAs 11 . In a study comparing a fully deflated or inflated standard LMA, blood was seen significantly more often on the deflated LMA (15.3%) compared to 0% of the inflated LMAs. In our study, following removal of the Portex laryngeal mask, blood was seen on the laryngeal mask in 12.2% of cases. This rate was surprisingly low, as the Portex laryngeal mask feels considerably stiffer than the standard LMA and it was our feeling that considerably more force was required for insertion. However, the cuff was inflated to some extent in over 80% of our cases, and this may have contributed to this lower than expected incidence.
In conclusion, we do not consider that the Portex laryngeal mask in its current configuration is a suitable alternative to the standard LMA. The majority of anaesthetists in our study considered it to be inferior, success at first placement was relatively lower than with the standard LMA, and we were unable to successfully place the Portex laryngeal mask in nearly 4% of patients. It would appear to us that the Portex laryngeal mask might need some design modifications before it becomes a real alternative to the standard LMA. In the meantime, it was our impression that it was easier to insert the Portex laryngeal mask if one chose a size smaller size than one would with the standard LMA.
